title: Treatment outcomes in 23 thoracic primitive neuroectodermal tumours: a retrospective study.
abstract: OBJECTIVE
  Thoracic primitive neuroectodermal tumour is an aggressive malignancy with poor survival despite multimodality treatment regimens. Early diagnosis of the tumour by histological, immunohistochemical, ultrastructural and cytogenetic techniques and early total surgical resection of the tumour with intensive chemoradiation may improve outcomes.
  
  
  METHODS
  Over 30 years, 23 patients (median age 29.5) with primitive neuroectodermal tumours (15 chest wall, 4 lung, 3 costovertebral sulcus and 1 anterior mediastinum) were diagnosed by transthoracic needle biopsy (43%) or excisional biopsy (57%). Treatment of a localized disease (Stage I and II) in 19 patients included surgery (wide excision of chest lesions in 11, 4 lung resections, excision of 3 costovertebral sulcus and 1 anterior mediastinal tumours, and resection of adjacent tissues involved by tumour en bloc) with adjuvant chemoradiation. Four metastatic chest wall tumours (Stage III) had chemotherapy and radiation alone.
  
  
  RESULTS
  Tumour recurred in 5 (2 chest wall, 2 costovertebral sulcus and 1 lung) requiring further chemotherapy, radiation and completion pneumonectomy for a lung recurrence. The incidence of recurrent tumour in 7 years for Stage I was 21 vs 40% (P=0.4) for Stage II lesions and 16% after the neoadjuvant chemotherapy vs 30% (P=0.4) after adjuvant chemoradiation. Four with recurrence, except one with a chest recurrence, succumbed to second relapse (78-96 months). All four Stage III chest tumours succumbed to advanced disease (30 months). The Kaplan-Meier disease-free survival of the overall group (23 patients) was 82±2% at 5 years and 64±3% at 10 years. The 10-year disease-free survival of 19 patients with localized tumours was 76%, but was high at 90% for chest wall tumours and low 33% for costovertebral sulcus tumours (P≤0.01). The 10-year disease-free survival was 86% for Stage I vs 60% (P=0.02) for Stage II tumours; and 83% for neoadjuvant vs 76% (P=0.06) for adjuvant chemotherapy and radiation.
  
  
  CONCLUSIONS
  The primitive neuroectodermal tumours are aggressive neoplasms with poor prognosis. Early diagnosis and total surgical excision of localized tumours with neoadjuvant or adjuvant chemotherapy and radiation improved disease-free survival.
authors: Department of Cardiovascular and Thoracic Surgery, Newark Beth Israel Medical Center, University of Medicine and Dentistry of New Jersey, Newark, NJ 07079-1110, USA.
authors: Srikrishna
authors: S
authors: Sirivella
authors: Isaac
authors: I
authors: Gielchinsky
mesh_terms: D000328:Adult; D001707:Biopsy, Needle; D059248:Chemoradiotherapy / Q000009:adverse effects / Q000401:mortality; D059186:Chemoradiotherapy, Adjuvant; D018450:Disease Progression; D018572:Disease-Free Survival; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D018241:Neuroectodermal Tumors, Primitive, Peripheral / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D009515:New Jersey; D011237:Predictive Value of Tests; D012086:Reoperation; D012189:Retrospective Studies; D013899:Thoracic Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D019616:Thoracic Surgical Procedures / Q000009:adverse effects / Q000401:mortality; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D055815:Young Adult
keywords: Askin tumour; Chemotherapy; Chest wall; Lung; Mediastinum; Radiation therapy
references: Histopathology. 1997 May;30(5):486-90
references: 9181373
references: Thorac Cardiovasc Surg. 2010 Aug;58(5):306-8
references: 20680911
references: Cancer. 1992 Feb 15;69(4):1012-20
references: 1310431
references: Arch Pathol Lab Med. 2001 Mar;125(3):397-9
references: 11231490
references: J Thorac Oncol. 2009 Feb;4(2):185-92
references: 19179894
references: Semin Diagn Pathol. 1996 Aug;13(3):184-203
references: 8875709
references: Int J Gynecol Pathol. 1993 Jul;12(3):270-5
references: 8344764
references: Eur J Cardiothorac Surg. 2009 Jan;35(1):185-7
references: 19036597
references: Hematol Oncol Clin North Am. 2005 Jun;19(3):501-25, vi-vii
references: 15939194
references: Chest. 1993 Jul;104(1):287-8
references: 8325087
references: Cancer. 1979 Jun;43(6):2438-51
references: 222426
references: Thorac Cardiovasc Surg. 2007 Oct;55(7):460-1
references: 17902071
references: Am J Surg Pathol. 1997 Mar;21(3):354-9
references: 9060607
references: N Engl J Med. 2003 Feb 20;348(8):694-701
references: 12594313
references: J Pediatr Surg. 1994 Feb;29(2):179-84; discussion 184-5
references: 8176588
references: Semin Diagn Pathol. 1996 Aug;13(3):213-41
references: 8875711
references: J Pathol. 1996 Feb;178(2):116-21
references: 8683375